Innovation
Leading the field
Our Innovation approach
Listening to our customers and understanding the market has been pivotal to Norbrook's success. We have always endeavoured to create differentiated products, offering our customers additional or improved features such as new dosing formats, alternative packaging options or combination of active ingredients to name but some. Our innovation teams have brought customer and market insights to life and translated them into the world-class veterinary pharmaceuticals.
How we Innovate
Norbrook's innovation process involves cross-functional teams who collaborate with in-country sales & marketing representatives.
The research and development phase is a multi-stage process which begins with the product concept. Due diligence is then extensively carried out on the viability of the product. The product proposal then moves through to the series of development stages, before continuing on to production and testing. This progresses to securing successful regulatory licences to allow for the launch of the product for sale in markets around the world. The development and launch process is lengthy, requiring upwards of five years or more from initial product concept through to a successful launch of the product onto the market.
The Norbrook product model primarily involves the use of molecules that are already known and established in the pharmaceutical industry. These are developed with their own unique selling points so that these products can help our customers grow their business and improve the health of animals.
Merging insights, science & safety
Our track record of developing and launching new products is testament to how embedded innovation is within our culture. We innovate at pace, embracing scientific progress while never compromising on safety. Some of our recent highlights include:
-
24 products launched within the last 5 years
-
10 products scheduled to launch within the next 3 years
-
Highest number of generic FDA approvals in 2022
-
Approved by the FDA, VMD and EMA
Spotlight on Innovation
Being first, being different
Norbrook has a long history of launching novel, differentiated products which have disrupted the market and offered customers a superior solution to treat and protect animals. Brands such as Closamectin, Thyronorm, Hexasol and Alamycin LA 300 are leaders in their respective categories.
Thyronorm
A global 1st for a liquid therapy to treat feline hyperthyroidism
Alamycin LA 300
Unique strength with multiple routes of administration and target species
